Ares Capital Corporation is holding a special meeting of stockholders on August 13, 2026, centered on a corporate-governance proposal that could give the business development company greater flexibility to issue common stock below its net asset value. The virtual meeting is scheduled for 1:30 p.m. Eastern Time, with stockholders voting on whether to authorize the company to pursue qualifying issuances under specified conditions.
The proposal does not authorize an immediate stock offering. Instead, it would provide Ares Capital’s board of directors with the authority to approve future issuances of common stock at prices below the company’s then-current net asset value per share. If approved, the authorization would remain effective for 12 months from the date of the special meeting.
The issue is significant from a corporate-law and shareholder-governance perspective because issuing shares below net asset value can affect the economic interests of existing stockholders. The proposal therefore places the decision within a framework that includes a limit on the number of shares that could be issued and continued oversight by the company’s board.
What Stockholders Are Being Asked to Approve
Ares Capital’s proposal would permit the company, with approval from its board of directors, to sell or otherwise issue shares of common stock at prices below the then-current net asset value per share. The authorization would be limited to an aggregate number of shares not exceeding 25% of the company’s outstanding common stock, subject to the conditions described in the company’s proxy materials.
The authorization would not require the company to complete an issuance. Ares Capital has stated that approval would simply provide flexibility to respond to circumstances that could arise during the authorization period.
That distinction is important. A shareholder vote approving the proposal would establish authority for potential future transactions, but any actual issuance would remain a separate corporate decision requiring board approval and compliance with applicable requirements.
Why the Proposal Matters
Net asset value is an important measure for business development companies because it reflects the value of their assets after liabilities are taken into account. When new shares are issued below NAV, the transaction can have implications for existing shareholders because new shares are being sold for less than the company’s reported per-share net asset value.
For that reason, below-NAV share issuance has historically received close attention in the business development company sector. Ares Capital’s proposal includes a 25% limit and a defined 12-month authorization period, providing boundaries around the authority being requested.
The company has also emphasized that it does not currently have plans to issue common stock below NAV. Instead, management has argued that advance authorization could allow the company to respond more quickly if market conditions change or if additional capital becomes necessary.
A Longstanding Governance Practice
Ares Capital has sought similar authorization from its stockholders repeatedly over the years. According to the company’s meeting materials, stockholders had approved comparable requests during the previous 17 years.
The company has said that it has used such authorization only once, in connection with its acquisition of Allied Capital during the significant market disruption and volatility of 2009 and 2010.
The historical record provides context for the current proposal. Rather than representing a commitment to conduct a new offering immediately, the request is primarily about maintaining an available financing option.
What the Vote Could Mean
If stockholders approve the proposal, Ares Capital’s board would have additional flexibility for potential capital-raising transactions during the following 12 months. Any issuance would still need to satisfy the conditions outlined in the proxy materials and applicable legal and regulatory requirements.
If the proposal is not approved, the company would not receive the requested authorization. That would leave any future capital-raising strategy subject to the authorities and limitations otherwise available to the company.
For shareholders, the central consideration is therefore not whether Ares Capital is immediately selling discounted shares, but whether management should have the flexibility to pursue such a transaction if circumstances later justify it.
The meeting also illustrates an important feature of corporate governance: shareholders can be asked to authorize a category of potential future action while leaving the decision to execute an actual transaction with the company’s board.
As the August 13 meeting proceeds, the formal voting results will determine whether Ares Capital receives the requested authority. Until those results are officially reported, the proposal itself remains the key development. For corporate-law observers, the meeting offers a timely example of how shareholder approval, board discretion and limitations on below-NAV equity issuance interact within the governance structure of a publicly traded business development company.